Recipharm AB
Climate Impact & Sustainability Data (2019, 2020, 2021, 2023)
Reporting Period: 2019
Environmental Metrics
ESG Focus Areas
- Reduce greenhouse gas emissions
- Supplier assessment and monitoring
- Develop internal governance
Environmental Achievements
- Reduced greenhouse gas emissions per employee by 22% compared to the previous year
Social Achievements
- 93 suppliers audited in connection to quality audits (31% increase compared to last year)
- Wasserburg sterile manufacturing facility in Germany became the first site certified to ISO 45001 occupational health and safety management system
Governance Achievements
- Cross-functional risk assessment of corruption risks conducted and mitigation plan established
- 85% of manufacturing operations certified according to ISO 14001
Climate Goals & Targets
- Not disclosed
- Conduct 40 additional on-site reviews at suppliers
- Reduce greenhouse gas emissions per employee by at least 3% each year
Environmental Challenges
- Supply chain disruptions due to Covid-19 pandemic (mentioned in CEO statement, not explicitly in sustainability section)
Mitigation Strategies
- CEO statement mentions anticipation of customers reevaluating supply chains and business continuity plans, favoring localized production and reliable suppliers. No specific mitigation strategies detailed in the sustainability report itself.
Supply Chain Management
Supplier Audits: 93/year
Responsible Procurement
- Recipharm Supplier Code of Conduct covering business ethics, labour practices, anti-corruption, human rights and environmental management
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: GRI Standards: Core option, UN Global Compact
Certifications: ISO 14001, ISO 45001
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- CDP rating improved to B-
Reporting Period: 2020
Environmental Metrics
ESG Focus Areas
- Reduced greenhouse gas emissions
- Supplier assessment and monitoring
- Develop internal governance
Environmental Achievements
- Reduced greenhouse gas emissions per employee by 4.5% in 2020
- Achieved ISO 14001 certifications in Paderno Dugnano, Masate, and Bengaluru.
Social Achievements
- Conducted 24 on-site supplier reviews (fewer than planned due to COVID-19)
- Implemented a comprehensive business continuity plan to protect employee wellbeing and ensure continued support for customers during the COVID-19 pandemic.
- No suppliers with potential negative environmental and/or social impact were identified in 2020.
Governance Achievements
- Further developed guidelines around processes for review, communication, and training to prevent corruption.
- Established organisation and processes for internal control.
- Three cases were reported through the whistleblowing system, with one leading to further investigation, but no misconduct was identified.
Climate Goals & Targets
- Achieve net-zero emissions
- Complete the overview of Recipharm’s manufacturing of antibiotics as part of the commitment to antimicrobial resistance (AMR).
- Reduce greenhouse gas emissions per employee by 3%.
Environmental Challenges
- COVID-19 pandemic posed operational challenges, including high absenteeism and restrictions on movement of people.
- Supply chain disruptions due to the COVID-19 pandemic.
- An incident in Monts, France, where an anesthetic product was accidentally released into the water treatment system and a nearby river.
- Remediation of an incident in Consort’s Cramlington operations (from 2019) took longer than expected.
Mitigation Strategies
- Implemented business continuity plans to protect employees and maintain customer support.
- Took immediate actions to investigate and mitigate the impacts of the incident in Monts, France, and implemented processes to prevent recurrence.
- Implemented further activities in Q4 2020 to improve operations in Cramlington, with expected improvements in 2021.
- Adjusted supply chains to mitigate the impact of external events.
Supply Chain Management
Supplier Audits: 24/year in 2020 (fewer than planned due to COVID-19)
Responsible Procurement
- Supplier Code of Conduct
Climate-Related Risks & Opportunities
Reporting Standards
Frameworks Used: GRI Standards: Core option, UN Global Compact
Certifications: ISO 14001, ISO 45001
Sustainable Products & Innovation
- Softmist spray nozzle technology (Resyca joint venture)
Reporting Period: 2021
Environmental Metrics
ESG Focus Areas
- Enabling Good Health
- Fair and Equal Workplace
- Responsible Resource Management
- Reduce Climate Impact
Environmental Achievements
- Reduced greenhouse gas emissions per employee by 27.2% in 2021
- Reduced waste by 8% and hazardous waste by 33% in 2021 compared to 2020
- 100% of electricity consumption covered by Energy Attribute Certificates (EACs) in 2021 to offset non-renewable sources
Social Achievements
- Launched new product quality KPIs
- Manufactured one of the Covid-19 vaccines
- Involved in SENSYO Pharmatech facility promoting vaccine independence in Morocco and Africa
- Code of Conduct training for all employees started, with around half completing it in 2021
- Accident rate decreased to 1.06 (from 1.92) per 1,000,000 hours worked
Governance Achievements
- Refined sustainability strategy and governance structure
- Created a new Head of Sustainability position
- A dedicated sustainability person joined the Board
- Conducted a materiality analysis with a third party
Climate Goals & Targets
- Investigating alignment with Science Based Targets initiative (SBTi)
- Source 85% of electricity from certified renewable sources by 2023
- Reduce, reuse and recycle waste towards local site-level waste objectives
- Continue ISO 45001 certification for remaining sites
Environmental Challenges
- Two sites still send waste to landfill
- Data consolidation difficulties due to new centralized governance model
- Covid-19 restrictions impacting supplier audits
Mitigation Strategies
- Initiatives to explore new waste management alternatives
- Plans to fine-tune and better consolidate Group’s HR reporting
- Plans to ramp up on-site supplier audits following easing of Covid-19 restrictions
Supply Chain Management
Supplier Audits: 40 in 2021
Responsible Procurement
- Supplier Code of Conduct covering business ethics, labour practices, anti-corruption, human rights, and environmental management
Climate-Related Risks & Opportunities
Opportunities
- Development of alternative inhaler propellants with lower GWP
Reporting Standards
Frameworks Used: GRI Standards: Core option, UN Global Compact
Certifications: ISO 14001, ISO 45001
Sustainable Products & Innovation
- Alternative inhaler propellants with lower GWP
Reporting Period: 2023
Environmental Metrics
ESG Focus Areas
- Reduce climate impact
- Increase resource efficiency
- Drive safe and ethical business
- Enable good health
Environmental Achievements
- Reduced greenhouse gas emissions (scope 1 and 2) by 13.5% compared with 2021.
- Reduced greenhouse gas emissions (scope 3) by 35.8% compared with 2021.
- 93% of electricity sourced from renewables.
Social Achievements
- First global Safety Week held, resulting in a 51% reduction in the lost-time accident rate for employees compared to 2022.
- 84% of permanent employees completed the employee engagement survey, with 65% responding positively to diversity and inclusion.
Governance Achievements
- Launched a new global Whistleblowing Policy and Hotline.
- Revised Recipharm Code of Conduct (to be launched in 2024).
Climate Goals & Targets
- Zero waste to landfill
- 100% of waste recycled
- 42.1% reduction of scope 1 and 2 emissions by 2030
- 25% reduction of scope 3 emissions by 2030
- 100% renewable electricity by 2024
- Maximum Lost Time Incident Rate of 0.2 by 2025
Environmental Challenges
- Sourcing renewable electricity in some markets.
- Supply of biogas.
- Ensuring optimal emission reduction investments across the global organization.
- Measuring water consumption at some sites.
- Some sites use chemicals that cannot be discharged into municipal wastewater drains.
- Promoting a safety reporting culture.
- Limited global overview of diversity and inclusion due to local approach.
- Customers often require the use of specific suppliers.
- Changing materials or suppliers can be a long administrative process.
- Dependence on single suppliers for particular products.
Mitigation Strategies
- Developing solutions with local partners for renewable electricity.
- Investigating improvements to biogas supply or switching to electrical boilers.
- Improving procurement capabilities, emission monitoring, and emission assessment during CAPEX evaluation.
- Improving data reporting on water consumption.
- Operating wastewater treatment plants at some sites.
- Improving near miss incident reporting.
- Developing structured processes for stakeholder dialogue and global D&I initiatives.
- Ensuring all suppliers work according to Recipharm standards.
- Developing a new policy, systems, and processes on third-party due diligence.
Supply Chain Management
Supplier Audits: 94 in 2023
Responsible Procurement
- Supplier Code of Conduct
Climate-Related Risks & Opportunities
Physical Risks
- Flooding
- Power outages
- Increasing temperatures
- Extreme heat waves
Transition Risks
- Regulatory changes
- Market shifts
Opportunities
- Development of energy-efficient products
Reporting Standards
Frameworks Used: GRI Standards 2021, UN Global Compact
Certifications: ISO 14001, ISO 45001
Third-party Assurance: KPMG AB
UN Sustainable Development Goals
- Not disclosed
Each sustainability focus area is aligned with a corresponding UN Sustainable Development Goal.
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed